Literature DB >> 3523368

Efficacy of endonasal neomycin-tixocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis.

G Cuenant, J P Stipon, G Plante-Longchamp, C Baudoin, Y Guerrier.   

Abstract

60 patients, aged 15-51 years, with chronic allergic or bacterial maxillary sinusitis, were entered in a controlled, double-blind study comparing the efficacy of endonasal irrigations of tixocortol pivalate (Pivalone)-neomycin and neomycin. The treatment lasted 11 days and was administered once daily. A ventilometric measurement of sinus pressure was performed every two endonasal irrigations to assess treatment efficacy. The percentage of nasal deobstruction was significantly higher with tixocortol pivalate-neomycin than with neomycin alone by the fifth examination (9th day) regardless of the etiology of the sinusitis (allergic or bacterial). After 11 days of treatment, significantly better results were obtained in cases of bacterial sinusitis (94% deobstruction with tixocortol pivalate-neomycin versus 74% with neomycin) than in cases of allergic sinusitis (69% deobstruction with tixocortol pivalate-neomycin versus 36% with neomycin).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3523368     DOI: 10.1159/000275873

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  13 in total

1.  Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Authors:  Umur Hatipo; Israel Rubinstein
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

Review 2.  Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines.

Authors:  Eli O Meltzer; Daniel L Hamilos
Journal:  Mayo Clin Proc       Date:  2011-04-13       Impact factor: 7.616

Review 3.  Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: systematic review and meta-analysis.

Authors:  Kornkiat Snidvongs; Larry Kalish; Raymond Sacks; Rahuram Sivasubramaniam; Daron Cope; Richard J Harvey
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

Review 4.  Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Authors:  Umur Hatipoğlu; Israel Rubinstein
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

5.  [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; K Hörmann
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

Review 6.  Decongestants, antihistamines and nasal irrigation for acute sinusitis in children.

Authors:  Nader Shaikh; Ellen R Wald
Journal:  Cochrane Database Syst Rev       Date:  2014-10-27

7.  Topical Drug Delivery for Chronic Rhinosinusitis.

Authors:  Jonathan Liang; Andrew P Lane
Journal:  Curr Otorhinolaryngol Rep       Date:  2012-12-27

8.  Indications, efficacy, and safety of intranasal corticosteriods in rhinosinusitis.

Authors:  Paul C Potter; Ruby Pawankar
Journal:  World Allergy Organ J       Date:  2012-01-13       Impact factor: 4.084

9.  Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches.

Authors:  Harsha H Kariyawasam; Glenis K Scadding
Journal:  Allergy Asthma Immunol Res       Date:  2011-09-01       Impact factor: 5.764

Review 10.  Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.

Authors:  Lee Yee Chong; Karen Head; Claire Hopkins; Carl Philpott; Anne G M Schilder; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.